← 產業報告目錄
Ophthalmic Drug Delivery Device Industry Research Report 2026
出版商 APO Research產業別 Medical Devices出版日期 2026-07-04頁數 131報告編號 APO-870b415852
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Ophthalmic Drug Delivery Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ophthalmic Drug Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ophthalmic Drug Delivery Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Ophthalmic Drug Delivery Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ophthalmic Drug Delivery Device include West Pharmaceutical Services, Inc., Terumo Corporation, Silgan Holdings Inc., Re-Vana Therapeutics, Owen Mumford, Ocumedic, Inc., Ocular Therapeutix, Nipro Corporation and Nemera, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ophthalmic Drug Delivery Device market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ophthalmic Drug Delivery Device Market by Company
West Pharmaceutical Services, Inc.
Terumo Corporation
Silgan Holdings Inc.
Re-Vana Therapeutics
Owen Mumford
Ocumedic, Inc.
Ocular Therapeutix
Nipro Corporation
Nemera
Mati Therapeutics, Inc.,
Kedalion Therapeutics
Gerresheimer
Gaplast GmbH
EyePoint Pharmaceuticals, Inc.
Biocorp Production
Becton Dickinson & Company
Bausch Health
AptarGroup
Aero Pump GmbH
Ophthalmic Drug Delivery Device Segment by Type
Multidose Eyedroppers
Add-On Devices
Squeeze Dispenser
Mist Sprayers
Contact Lenses
Pre-Filled Syringes
Others
Ophthalmic Drug Delivery Device Segment by Application
Clinics
Hospitals
Homecare
Others
Ophthalmic Drug Delivery Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Drug Delivery Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Drug Delivery Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Drug Delivery Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ophthalmic Drug Delivery Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ophthalmic Drug Delivery Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ophthalmic Drug Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Ophthalmic Drug Delivery Device Market Size (2021-2032)
2.2.2 Global Ophthalmic Drug Delivery Device Sales (2021-2032)
2.2.3 Global Ophthalmic Drug Delivery Device Market Average Price (2021-2032)
2.3 Ophthalmic Drug Delivery Device by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Multidose Eyedroppers
2.3.3 Add-On Devices
2.3.4 Squeeze Dispenser
2.3.5 Mist Sprayers
2.3.6 Contact Lenses
2.3.7 Pre-Filled Syringes
2.3.8 Others
2.4 Ophthalmic Drug Delivery Device by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Clinics
2.4.3 Hospitals
2.4.4 Homecare
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Ophthalmic Drug Delivery Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Ophthalmic Drug Delivery Device Sales (k units) of Manufacturers (2021-2026)
3.3 Global Ophthalmic Drug Delivery Device Revenue of Manufacturers (2021-2026)
3.4 Global Ophthalmic Drug Delivery Device Average Price by Manufacturers (2021-2026)
3.5 Global Ophthalmic Drug Delivery Device Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Ophthalmic Drug Delivery Device, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Ophthalmic Drug Delivery Device, Product Type & Application
3.8 Global Manufacturers of Ophthalmic Drug Delivery Device, Established Date
3.9 Global Ophthalmic Drug Delivery Device Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 West Pharmaceutical Services, Inc.
4.1.1 West Pharmaceutical Services, Inc. Company Information
4.1.2 West Pharmaceutical Services, Inc. Business Overview
4.1.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.1.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolio
4.1.5 West Pharmaceutical Services, Inc. Recent Developments
4.2 Terumo Corporation
4.2.1 Terumo Corporation Company Information
4.2.2 Terumo Corporation Business Overview
4.2.3 Terumo Corporation Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolio
4.2.5 Terumo Corporation Recent Developments
4.3 Silgan Holdings Inc.
4.3.1 Silgan Holdings Inc. Company Information
4.3.2 Silgan Holdings Inc. Business Overview
4.3.3 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolio
4.3.5 Silgan Holdings Inc. Recent Developments
4.4 Re-Vana Therapeutics
4.4.1 Re-Vana Therapeutics Company Information
4.4.2 Re-Vana Therapeutics Business Overview
4.4.3 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
4.4.5 Re-Vana Therapeutics Recent Developments
4.5 Owen Mumford
4.5.1 Owen Mumford Company Information
4.5.2 Owen Mumford Business Overview
4.5.3 Owen Mumford Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Owen Mumford Ophthalmic Drug Delivery Device Product Portfolio
4.5.5 Owen Mumford Recent Developments
4.6 Ocumedic, Inc.
4.6.1 Ocumedic, Inc. Company Information
4.6.2 Ocumedic, Inc. Business Overview
4.6.3 Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolio
4.6.5 Ocumedic, Inc. Recent Developments
4.7 Ocular Therapeutix
4.7.1 Ocular Therapeutix Company Information
4.7.2 Ocular Therapeutix Business Overview
4.7.3 Ocular Therapeutix Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolio
4.7.5 Ocular Therapeutix Recent Developments
4.8 Nipro Corporation
4.8.1 Nipro Corporation Company Information
4.8.2 Nipro Corporation Business Overview
4.8.3 Nipro Corporation Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolio
4.8.5 Nipro Corporation Recent Developments
4.9 Nemera
4.9.1 Nemera Company Information
4.9.2 Nemera Business Overview
4.9.3 Nemera Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Nemera Ophthalmic Drug Delivery Device Product Portfolio
4.9.5 Nemera Recent Developments
4.10 Mati Therapeutics, Inc.,
4.10.1 Mati Therapeutics, Inc., Company Information
4.10.2 Mati Therapeutics, Inc., Business Overview
4.10.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolio
4.10.5 Mati Therapeutics, Inc., Recent Developments
4.11 Kedalion Therapeutics
4.11.1 Kedalion Therapeutics Company Information
4.11.2 Kedalion Therapeutics Business Overview
4.11.3 Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
4.11.5 Kedalion Therapeutics Recent Developments
4.12 Gerresheimer
4.12.1 Gerresheimer Company Information
4.12.2 Gerresheimer Business Overview
4.12.3 Gerresheimer Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Gerresheimer Ophthalmic Drug Delivery Device Product Portfolio
4.12.5 Gerresheimer Recent Developments
4.13 Gaplast GmbH
4.13.1 Gaplast GmbH Company Information
4.13.2 Gaplast GmbH Business Overview
4.13.3 Gaplast GmbH Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolio
4.13.5 Gaplast GmbH Recent Developments
4.14 EyePoint Pharmaceuticals, Inc.
4.14.1 EyePoint Pharmaceuticals, Inc. Company Information
4.14.2 EyePoint Pharmaceuticals, Inc. Business Overview
4.14.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.14.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolio
4.14.5 EyePoint Pharmaceuticals, Inc. Recent Developments
4.15 Biocorp Production
4.15.1 Biocorp Production Company Information
4.15.2 Biocorp Production Business Overview
4.15.3 Biocorp Production Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Biocorp Production Ophthalmic Drug Delivery Device Product Portfolio
4.15.5 Biocorp Production Recent Developments
4.16 Becton Dickinson & Company
4.16.1 Becton Dickinson & Company Company Information
4.16.2 Becton Dickinson & Company Business Overview
4.16.3 Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.16.4 Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolio
4.16.5 Becton Dickinson & Company Recent Developments
4.17 Bausch Health
4.17.1 Bausch Health Company Information
4.17.2 Bausch Health Business Overview
4.17.3 Bausch Health Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.17.4 Bausch Health Ophthalmic Drug Delivery Device Product Portfolio
4.17.5 Bausch Health Recent Developments
4.18 AptarGroup
4.18.1 AptarGroup Company Information
4.18.2 AptarGroup Business Overview
4.18.3 AptarGroup Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.18.4 AptarGroup Ophthalmic Drug Delivery Device Product Portfolio
4.18.5 AptarGroup Recent Developments
4.19 Aero Pump GmbH
4.19.1 Aero Pump GmbH Company Information
4.19.2 Aero Pump GmbH Business Overview
4.19.3 Aero Pump GmbH Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.19.4 Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolio
4.19.5 Aero Pump GmbH Recent Developments
5 Global Ophthalmic Drug Delivery Device Market Scenario by Region
5.1 Global Ophthalmic Drug Delivery Device Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Ophthalmic Drug Delivery Device Sales by Region: 2021-2032
5.2.1 Global Ophthalmic Drug Delivery Device Sales by Region: 2021-2026
5.2.2 Global Ophthalmic Drug Delivery Device Sales by Region: 2027-2032
5.3 Global Ophthalmic Drug Delivery Device Revenue by Region: 2021-2032
5.3.1 Global Ophthalmic Drug Delivery Device Revenue by Region: 2021-2026
5.3.2 Global Ophthalmic Drug Delivery Device Revenue by Region: 2027-2032
5.4 North America Ophthalmic Drug Delivery Device Market Facts & Figures by Country
5.4.1 North America Ophthalmic Drug Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Ophthalmic Drug Delivery Device Sales by Country (2021-2032)
5.4.3 North America Ophthalmic Drug Delivery Device Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Ophthalmic Drug Delivery Device Market Facts & Figures by Country
5.5.1 Europe Ophthalmic Drug Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Ophthalmic Drug Delivery Device Sales by Country (2021-2032)
5.5.3 Europe Ophthalmic Drug Delivery Device Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Ophthalmic Drug Delivery Device Market Facts & Figures by Country
5.6.1 Asia Pacific Ophthalmic Drug Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Ophthalmic Drug Delivery Device Sales by Country (2021-2032)
5.6.3 Asia Pacific Ophthalmic Drug Delivery Device Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Ophthalmic Drug Delivery Device Market Facts & Figures by Country
5.7.1 South America Ophthalmic Drug Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Ophthalmic Drug Delivery Device Sales by Country (2021-2032)
5.7.3 South America Ophthalmic Drug Delivery Device Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.7.7 Colombia
5.8 Middle East and Africa Ophthalmic Drug Delivery Device Market Facts & Figures by Country
5.8.1 Middle East and Africa Ophthalmic Drug Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Ophthalmic Drug Delivery Device Sales by Country (2021-2032)
5.8.3 Middle East and Africa Ophthalmic Drug Delivery Device Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Ophthalmic Drug Delivery Device Sales by Type (2021-2032)
6.1.1 Global Ophthalmic Drug Delivery Device Sales by Type (2021-2032) & (k units)
6.1.2 Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2021-2032)
6.2 Global Ophthalmic Drug Delivery Device Revenue by Type (2021-2032)
6.2.1 Global Ophthalmic Drug Delivery Device Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2021-2032)
6.3 Global Ophthalmic Drug Delivery Device Price by Type (2021-2032)
7 Segment by Application
7.1 Global Ophthalmic Drug Delivery Device Sales by Application (2021-2032)
7.1.1 Global Ophthalmic Drug Delivery Device Sales by Application (2021-2032) & (k units)
7.1.2 Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2021-2032)
7.2 Global Ophthalmic Drug Delivery Device Revenue by Application (2021-2032)
7.2.1 Global Ophthalmic Drug Delivery Device Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2021-2032)
7.3 Global Ophthalmic Drug Delivery Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Ophthalmic Drug Delivery Device Value Chain Analysis
8.1.1 Ophthalmic Drug Delivery Device Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Ophthalmic Drug Delivery Device Production Mode & Process
8.2 Ophthalmic Drug Delivery Device Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Ophthalmic Drug Delivery Device Distributors
8.2.3 Ophthalmic Drug Delivery Device Customers
9 Global Ophthalmic Drug Delivery Device Analyzing Market Dynamics
9.1 Ophthalmic Drug Delivery Device Industry Trends
9.2 Ophthalmic Drug Delivery Device Industry Drivers
9.3 Ophthalmic Drug Delivery Device Industry Opportunities and Challenges
9.4 Ophthalmic Drug Delivery Device Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Ophthalmic Drug Delivery Device Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Ophthalmic Drug Delivery Device Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Ophthalmic Drug Delivery Device Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Ophthalmic Drug Delivery Device Revenue of Manufacturers (2021-2026)
Table 9. Global Ophthalmic Drug Delivery Device Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Ophthalmic Drug Delivery Device Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Ophthalmic Drug Delivery Device Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Ophthalmic Drug Delivery Device, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Ophthalmic Drug Delivery Device, Product Type & Application
Table 14. Global Ophthalmic Drug Delivery Device Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Ophthalmic Drug Delivery Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. West Pharmaceutical Services, Inc. Company Information
Table 19. West Pharmaceutical Services, Inc. Business Overview
Table 20. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolio
Table 22. West Pharmaceutical Services, Inc. Recent Developments
Table 23. Terumo Corporation Company Information
Table 24. Terumo Corporation Business Overview
Table 25. Terumo Corporation Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolio
Table 27. Terumo Corporation Recent Developments
Table 28. Silgan Holdings Inc. Company Information
Table 29. Silgan Holdings Inc. Business Overview
Table 30. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolio
Table 32. Silgan Holdings Inc. Recent Developments
Table 33. Re-Vana Therapeutics Company Information
Table 34. Re-Vana Therapeutics Business Overview
Table 35. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
Table 37. Re-Vana Therapeutics Recent Developments
Table 38. Owen Mumford Company Information
Table 39. Owen Mumford Business Overview
Table 40. Owen Mumford Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. Owen Mumford Ophthalmic Drug Delivery Device Product Portfolio
Table 42. Owen Mumford Recent Developments
Table 43. Ocumedic, Inc. Company Information
Table 44. Ocumedic, Inc. Business Overview
Table 45. Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolio
Table 47. Ocumedic, Inc. Recent Developments
Table 48. Ocular Therapeutix Company Information
Table 49. Ocular Therapeutix Business Overview
Table 50. Ocular Therapeutix Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolio
Table 52. Ocular Therapeutix Recent Developments
Table 53. Nipro Corporation Company Information
Table 54. Nipro Corporation Business Overview
Table 55. Nipro Corporation Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolio
Table 57. Nipro Corporation Recent Developments
Table 58. Nemera Company Information
Table 59. Nemera Business Overview
Table 60. Nemera Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Nemera Ophthalmic Drug Delivery Device Product Portfolio
Table 62. Nemera Recent Developments
Table 63. Mati Therapeutics, Inc., Company Information
Table 64. Mati Therapeutics, Inc., Business Overview
Table 65. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolio
Table 67. Mati Therapeutics, Inc., Recent Developments
Table 68. Kedalion Therapeutics Company Information
Table 69. Kedalion Therapeutics Business Overview
Table 70. Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
Table 72. Kedalion Therapeutics Recent Developments
Table 73. Gerresheimer Company Information
Table 74. Gerresheimer Business Overview
Table 75. Gerresheimer Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. Gerresheimer Ophthalmic Drug Delivery Device Product Portfolio
Table 77. Gerresheimer Recent Developments
Table 78. Gaplast GmbH Company Information
Table 79. Gaplast GmbH Business Overview
Table 80. Gaplast GmbH Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolio
Table 82. Gaplast GmbH Recent Developments
Table 83. EyePoint Pharmaceuticals, Inc. Company Information
Table 84. EyePoint Pharmaceuticals, Inc. Business Overview
Table 85. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolio
Table 87. EyePoint Pharmaceuticals, Inc. Recent Developments
Table 88. Biocorp Production Company Information
Table 89. Biocorp Production Business Overview
Table 90. Biocorp Production Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. Biocorp Production Ophthalmic Drug Delivery Device Product Portfolio
Table 92. Biocorp Production Recent Developments
Table 93. Becton Dickinson & Company Company Information
Table 94. Becton Dickinson & Company Business Overview
Table 95. Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolio
Table 97. Becton Dickinson & Company Recent Developments
Table 98. Bausch Health Company Information
Table 99. Bausch Health Business Overview
Table 100. Bausch Health Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 101. Bausch Health Ophthalmic Drug Delivery Device Product Portfolio
Table 102. Bausch Health Recent Developments
Table 103. AptarGroup Company Information
Table 104. AptarGroup Business Overview
Table 105. AptarGroup Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 106. AptarGroup Ophthalmic Drug Delivery Device Product Portfolio
Table 107. AptarGroup Recent Developments
Table 108. Aero Pump GmbH Company Information
Table 109. Aero Pump GmbH Business Overview
Table 110. Aero Pump GmbH Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 111. Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolio
Table 112. Aero Pump GmbH Recent Developments
Table 113. Global Ophthalmic Drug Delivery Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 114. Global Ophthalmic Drug Delivery Device Sales by Region (2021-2026) & (k units)
Table 115. Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2021-2026)
Table 116. Global Ophthalmic Drug Delivery Device Sales by Region (2027-2032) & (k units)
Table 117. Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2027-2032)
Table 118. Global Ophthalmic Drug Delivery Device Revenue by Region (2021-2026) & (US$ Million)
Table 119. Global Ophthalmic Drug Delivery Device Revenue Market Share by Region (2021-2026)
Table 120. Global Ophthalmic Drug Delivery Device Revenue by Region (2027-2032) & (US$ Million)
Table 121. Global Ophthalmic Drug Delivery Device Revenue Market Share by Region (2027-2032)
Table 122. North America Ophthalmic Drug Delivery Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. North America Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units)
Table 124. North America Ophthalmic Drug Delivery Device Sales by Country (2027-2032) & (k units)
Table 125. North America Ophthalmic Drug Delivery Device Revenue by Country (2021-2026) & (US$ Million)
Table 126. North America Ophthalmic Drug Delivery Device Revenue by Country (2027-2032) & (US$ Million)
Table 127. Europe Ophthalmic Drug Delivery Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. Europe Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units)
Table 129. Europe Ophthalmic Drug Delivery Device Sales by Country (2027-2032) & (k units)
Table 130. Europe Ophthalmic Drug Delivery Device Revenue by Country (2021-2026) & (US$ Million)
Table 131. Europe Ophthalmic Drug Delivery Device Revenue by Country (2027-2032) & (US$ Million)
Table 132. Asia Pacific Ophthalmic Drug Delivery Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 133. Asia Pacific Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units)
Table 134. Asia Pacific Ophthalmic Drug Delivery Device Sales by Country (2027-2032) & (k units)
Table 135. Asia Pacific Ophthalmic Drug Delivery Device Revenue by Country (2021-2026) & (US$ Million)
Table 136. Asia Pacific Ophthalmic Drug Delivery Device Revenue by Country (2027-2032) & (US$ Million)
Table 137. South America Ophthalmic Drug Delivery Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 138. South America Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units)
Table 139. South America Ophthalmic Drug Delivery Device Sales by Country (2027-2032) & (k units)
Table 140. South America Ophthalmic Drug Delivery Device Revenue by Country (2021-2026) & (US$ Million)
Table 141. South America Ophthalmic Drug Delivery Device Revenue by Country (2027-2032) & (US$ Million)
Table 142. Middle East and Africa Ophthalmic Drug Delivery Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 143. Middle East and Africa Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units)
Table 144. Middle East and Africa Ophthalmic Drug Delivery Device Sales by Country (2027-2032) & (k units)
Table 145. Middle East and Africa Ophthalmic Drug Delivery Device Revenue by Country (2021-2026) & (US$ Million)
Table 146. Middle East and Africa Ophthalmic Drug Delivery Device Revenue by Country (2027-2032) & (US$ Million)
Table 147. Global Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (k units)
Table 148. Global Ophthalmic Drug Delivery Device Sales by Type (2027-2032) & (k units)
Table 149. Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2021-2026)
Table 150. Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2027-2032)
Table 151. Global Ophthalmic Drug Delivery Device Revenue by Type (2021-2026) & (US$ Million)
Table 152. Global Ophthalmic Drug Delivery Device Revenue by Type (2027-2032) & (US$ Million)
Table 153. Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2021-2026)
Table 154. Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2027-2032)
Table 155. Global Ophthalmic Drug Delivery Device Price by Type (2021-2026) & (USD/unit)
Table 156. Global Ophthalmic Drug Delivery Device Price by Type (2027-2032) & (USD/unit)
Table 157. Global Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (k units)
Table 158. Global Ophthalmic Drug Delivery Device Sales by Application (2027-2032) & (k units)
Table 159. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2021-2026)
Table 160. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2027-2032)
Table 161. Global Ophthalmic Drug Delivery Device Revenue by Application (2021-2026) & (US$ Million)
Table 162. Global Ophthalmic Drug Delivery Device Revenue by Application (2027-2032) & (US$ Million)
Table 163. Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2021-2026)
Table 164. Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2027-2032)
Table 165. Global Ophthalmic Drug Delivery Device Price by Application (2021-2026) & (USD/unit)
Table 166. Global Ophthalmic Drug Delivery Device Price by Application (2027-2032) & (USD/unit)
Table 167. Key Raw Materials
Table 168. Raw Materials Key Suppliers
Table 169. Ophthalmic Drug Delivery Device Distributors List
Table 170. Ophthalmic Drug Delivery Device Customers List
Table 171. Ophthalmic Drug Delivery Device Industry Trends
Table 172. Ophthalmic Drug Delivery Device Industry Drivers
Table 173. Ophthalmic Drug Delivery Device Industry Restraints
Table 174. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Ophthalmic Drug Delivery Device Product Image
Figure 5. Global Ophthalmic Drug Delivery Device Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Ophthalmic Drug Delivery Device Market Size (2021-2032) & (US$ Million)
Figure 7. Global Ophthalmic Drug Delivery Device Sales (2021-2032) & (k units)
Figure 8. Global Ophthalmic Drug Delivery Device Average Price (USD/unit) & (2021-2032)
Figure 9. Multidose Eyedroppers Product Image
Figure 10. Add-On Devices Product Image
Figure 11. Squeeze Dispenser Product Image
Figure 12. Mist Sprayers Product Image
Figure 13. Contact Lenses Product Image
Figure 14. Pre-Filled Syringes Product Image
Figure 15. Others Product Image
Figure 16. Clinics Product Image
Figure 17. Hospitals Product Image
Figure 18. Homecare Product Image
Figure 19. Others Product Image
Figure 20. Global Ophthalmic Drug Delivery Device Revenue Share by Manufacturers in 2025
Figure 21. Global Manufacturers of Ophthalmic Drug Delivery Device, Manufacturing Sites & Headquarters
Figure 22. Global Top 5 and 10 Ophthalmic Drug Delivery Device Players Market Share by Revenue in 2025
Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 24. Global Ophthalmic Drug Delivery Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 25. Global Ophthalmic Drug Delivery Device Sales by Region in 2025
Figure 26. Global Ophthalmic Drug Delivery Device Revenue by Region in 2025
Figure 27. North America Ophthalmic Drug Delivery Device Market Size by Country in 2025
Figure 28. North America Ophthalmic Drug Delivery Device Sales Market Share by Country (2021-2032)
Figure 29. North America Ophthalmic Drug Delivery Device Revenue Market Share by Country (2021-2032)
Figure 30. United States Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. Canada Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Mexico Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Europe Ophthalmic Drug Delivery Device Market Size by Country in 2025
Figure 34. Europe Ophthalmic Drug Delivery Device Sales Market Share by Country (2021-2032)
Figure 35. Europe Ophthalmic Drug Delivery Device Revenue Market Share by Country (2021-2032)
Figure 36. Germany Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. France Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. U.K. Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Italy Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Russia Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Spain Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Netherlands Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Switzerland Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Sweden Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Poland Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Asia Pacific Ophthalmic Drug Delivery Device Market Size by Country in 2025
Figure 47. Asia Pacific Ophthalmic Drug Delivery Device Sales Market Share by Country (2021-2032)
Figure 48. Asia Pacific Ophthalmic Drug Delivery Device Revenue Market Share by Country (2021-2032)
Figure 49. China Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Japan Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. South Korea Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. India Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. Australia Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 54. Taiwan Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Southeast Asia Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Southeast Asia Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. South America Ophthalmic Drug Delivery Device Market Size by Country in 2025
Figure 58. South America Ophthalmic Drug Delivery Device Sales Market Share by Country (2021-2032)
Figure 59. South America Ophthalmic Drug Delivery Device Revenue Market Share by Country (2021-2032)
Figure 60. Brazil Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. Argentina Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Chile Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Colombia Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Middle East and Africa Ophthalmic Drug Delivery Device Market Size by Country in 2025
Figure 65. Middle East and Africa Ophthalmic Drug Delivery Device Sales Market Share by Country (2021-2032)
Figure 66. Middle East and Africa Ophthalmic Drug Delivery Device Revenue Market Share by Country (2021-2032)
Figure 67. Egypt Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 68. South Africa Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 69. Israel Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 70. Türkiye Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 71. GCC Countries Ophthalmic Drug Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 72. Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2021-2032)
Figure 73. Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2021-2032)
Figure 74. Global Ophthalmic Drug Delivery Device Price (USD/unit) by Type (2021-2032)
Figure 75. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2021-2032)
Figure 76. Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2021-2032)
Figure 77. Global Ophthalmic Drug Delivery Device Price (USD/unit) by Application (2021-2032)
Figure 78. Ophthalmic Drug Delivery Device Value Chain
Figure 79. Ophthalmic Drug Delivery Device Production Mode & Process
Figure 80. Direct Comparison with Distribution Share
Figure 81. Distributors Profiles
Figure 82. Ophthalmic Drug Delivery Device Industry Opportunities and Challenges
提及公司
West Pharmaceutical Services, Inc.Terumo CorporationSilgan Holdings Inc.Re-Vana TherapeuticsOwen MumfordOcumedic, Inc.Ocular TherapeutixNipro CorporationNemeraMati Therapeutics, Inc.,Kedalion TherapeuticsGerresheimerGaplast GmbHEyePoint Pharmaceuticals, Inc.Biocorp ProductionBecton Dickinson & CompanyBausch HealthAptarGroupAero Pump GmbH
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們